NCT07659795
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07659795
Title A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer (TARGET-D 203)
Acronym TARGET-D 203
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
START New Jersey RECRUITING East Brunswick New Jersey 08816 United States Details
START Dallas Fort Worth RECRUITING Fort Worth Texas 76104 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field